ArticlePolymers2024
Polymer Bionanocomposites Based on a P3BH/Polyurethane Matrix with Organomodified Montmorillonite-Mechanical and Thermal Properties, Biodegradability, and Cytotoxicity.
Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
In the present work, hybrid nanobiocomposites based on poly(3-hydroxybutyrate), P3HB, with the use of aromatic linear polyurethane as modifier and organic nanoclay, Cloisite 30B, as a nanofiller were produced. The aromatic linear polyurethane (PU) was synthesized in a reaction of diphenylmethane 4,4'-diisocyanate and polyethylene glycol with a molecular mass of 1000 g/mole. The obtained nanobiocomposites were characterized by the small-angle X-ray scattering technique, scanning electron microscopy, Fourier infrared spectroscopy, thermogravimetry, and differential scanning calorimetry, and moreover, their selected mechanical properties, biodegradability, and cytotoxicity were tested. The effect of the organomodified montmorillonite presence in the biocomposites on their properties was investigated and compared to those of the native P3HB and the P3HB-PU composition. The obtained hybrid nanobiocomposites have an exfoliated structure. The presence and content of Cloisite 30B influence the P3HB-PU composition's properties, and 2 wt.% Cloisite 30B leads to the best improvement in the aforementioned properties. The obtained results indicate that the thermal stability and mechanical properties of P3HB were improved, particularly in terms of increasing the degradation temperature, reducing hardness, and increasing impact strength, which were also confirmed by the morphological analysis of these bionanocomposites. However, the presence of organomodified montmorillonite in the obtained polymer biocomposites decreased their biodegradability slightly. The produced hybrid polymer nanobiocomposites have tailored mechanical and thermal properties and processing conditions for their expected application in the production of biodegradable, short-lived products for agriculture. Moreover, in vitro studies on human skin fibroblasts and keratinocytes showed their satisfactory biocompatibility and low cytotoxicity, which make them safe when in contact with the human body, for instance, in biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.